Free Trial

Silvercrest Asset Management Group LLC Has $25.68 Million Stake in Exponent, Inc. (NASDAQ:EXPO)

Exponent logo with Business Services background

Silvercrest Asset Management Group LLC grew its stake in Exponent, Inc. (NASDAQ:EXPO - Free Report) by 4.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 288,240 shares of the business services provider's stock after acquiring an additional 11,720 shares during the period. Silvercrest Asset Management Group LLC owned 0.57% of Exponent worth $25,682,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Barclays PLC grew its holdings in Exponent by 219.0% during the third quarter. Barclays PLC now owns 96,526 shares of the business services provider's stock worth $11,127,000 after purchasing an additional 66,263 shares during the period. Allspring Global Investments Holdings LLC grew its holdings in Exponent by 223.4% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 6,158 shares of the business services provider's stock worth $541,000 after purchasing an additional 4,254 shares during the period. KBC Group NV grew its holdings in Exponent by 62.4% during the fourth quarter. KBC Group NV now owns 2,274 shares of the business services provider's stock worth $203,000 after purchasing an additional 874 shares during the period. PineStone Asset Management Inc. grew its holdings in Exponent by 12.4% during the fourth quarter. PineStone Asset Management Inc. now owns 98,311 shares of the business services provider's stock worth $8,760,000 after purchasing an additional 10,811 shares during the period. Finally, Empowered Funds LLC grew its holdings in Exponent by 28.8% during the fourth quarter. Empowered Funds LLC now owns 12,272 shares of the business services provider's stock worth $1,093,000 after purchasing an additional 2,747 shares during the period. Institutional investors own 92.37% of the company's stock.

Exponent Stock Performance

Exponent stock traded down $0.64 during midday trading on Tuesday, reaching $79.32. 234,525 shares of the company's stock were exchanged, compared to its average volume of 244,943. Exponent, Inc. has a 52 week low of $73.37 and a 52 week high of $115.75. The firm has a market cap of $4.03 billion, a price-to-earnings ratio of 37.42 and a beta of 0.95. The stock's 50-day simple moving average is $79.22 and its 200 day simple moving average is $87.63.

Exponent (NASDAQ:EXPO - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The business services provider reported $0.52 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.48 by $0.04. Exponent had a return on equity of 27.27% and a net margin of 19.52%. The company had revenue of $137.44 million during the quarter, compared to analysts' expectations of $134.63 million. During the same quarter in the previous year, the company posted $0.59 earnings per share. The business's revenue was up .2% on a year-over-year basis. Research analysts forecast that Exponent, Inc. will post 1.98 earnings per share for the current year.

Exponent Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 20th. Stockholders of record on Friday, June 6th will be issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.51%. The ex-dividend date of this dividend is Friday, June 6th. Exponent's dividend payout ratio is presently 58.54%.

Insider Transactions at Exponent

In other news, VP Richard Reiss sold 1,736 shares of Exponent stock in a transaction that occurred on Wednesday, February 26th. The shares were sold at an average price of $85.93, for a total value of $149,174.48. Following the completion of the sale, the vice president now directly owns 1,800 shares in the company, valued at approximately $154,674. The trade was a 49.10% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 2.10% of the company's stock.

About Exponent

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Recommended Stories

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Should You Invest $1,000 in Exponent Right Now?

Before you consider Exponent, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.

While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs
New AI Deals Just Sent These 4 Infrastructure Stocks Soaring

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines